These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors. McInnes GT. J Hum Hypertens; 2011 Jun; 25(6):343-5. PubMed ID: 21390054 [No Abstract] [Full Text] [Related]
11. Two amlodipine/ARB combinations for hypertension. Med Lett Drugs Ther; 2007 Dec 17; 49(1276):101-2. PubMed ID: 18084152 [No Abstract] [Full Text] [Related]
14. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study). Nesbitt SD, Shojaee A, Maa JF, Weir MR. J Hum Hypertens; 2013 Jul 17; 27(7):445-52. PubMed ID: 23254596 [Abstract] [Full Text] [Related]
15. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy. Hsueh WA, Shojaee A, Maa JF, Neutel JM. Curr Med Res Opin; 2012 Nov 17; 28(11):1809-18. PubMed ID: 23072496 [Abstract] [Full Text] [Related]
16. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy. Neutel J, Shojaee A, Maa JF. Adv Ther; 2012 Jun 17; 29(6):508-23. PubMed ID: 22773358 [Abstract] [Full Text] [Related]
17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May 17; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
18. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study. Punzi HA. Ther Adv Cardiovasc Dis; 2014 Feb 17; 8(1):12-21. PubMed ID: 24492985 [Abstract] [Full Text] [Related]
19. [From the beginning -- a strong-acting and well tolerable antihypertensive agent. The recipe against constant change]. MMW Fortschr Med; 2003 Dec 04; 145(49):57. PubMed ID: 14963998 [No Abstract] [Full Text] [Related]
20. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients. Cardiovasc J Afr; 2008 Dec 04; 19(3):163. PubMed ID: 18568181 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]